A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
Completed · Phase 2 · Has a placebo group
Conditions studied: Moderate to Severe Ulcerative Colitis
In brief
This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).
Key facts
- Study ID
- NCT04700449
- Run by
- Connect Biopharm LLC
- People needed
- 145
- Starts
- 2019-02-27
- Expected to finish
- 2022-11-10
- Last updated by the study team
- 2024-05-06
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Connect Investigative Site 2308 — Mission Hills, California, United States
- Connect Investigative Site 2314 — Hialeah, Florida, United States
- Connect Investigative Site 2309 — Homestead, Florida, United States
- Connect Investigative Site 2320 — Kissimmee, Florida, United States
- Connect Investigative Site 2318 — Miami, Florida, United States
- Connect Investigative Site 2302 — Orlando, Florida, United States
- Connect Investigative Site 2304 — Orlando, Florida, United States
- Connect Investigative Site 2306 — Orlando, Florida, United States
- Connect Investigative Site 2307 — Atlanta, Georgia, United States
- Connect Investigative Site 2315 — Cincinnati, Ohio, United States
- Connect Investigative Site 2321 — Oklahoma City, Oklahoma, United States
- Connect Investigative Site 2311 — Cypress, Texas, United States
- Connect Investigative Site 2319 — San Antonio, Texas, United States
- Connect Investigative Site 2018 — Hefei, Anhui, China
- Connect Investigative Site 2004 — Hefei, Anhui, China
- Connect Investigative Site 2008 — Beijing, Beijing Municipality, China
- Connect Investigative Site 2001 — Beijing, Beijing Municipality, China
- Connect Investigative Site 2015 — Jilin City, Changchun, China
- Connect Investigative Site 2006 — Fuzhou, Fujian, China
- Connect Investigative Site 2012 — Xiamen, Fujian, China
- Connect Investigative Site 2003 — Guangzhou, Guangdong, China
- Connect Investigative Site 2009 — Guangzhou, Guangdong, China
- Connect Investigative Site 2017 — Shenzhen, Guangdong, China
- Connect Investigative Site 2021 — Shenzhen, Guangdong, China
- Connect Investigative Site 2316 — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.